Literature DB >> 25931254

Early detection of sporadic pancreatic cancer: summative review.

Suresh T Chari1, Kimberly Kelly, Michael A Hollingsworth, Sarah P Thayer, David A Ahlquist, Dana K Andersen, Surinder K Batra, Teresa A Brentnall, Marcia Canto, Deborah F Cleeter, Matthew A Firpo, Sanjiv Sam Gambhir, Vay Liang W Go, O Joe Hines, Barbara J Kenner, David S Klimstra, Markus M Lerch, Michael J Levy, Anirban Maitra, Sean J Mulvihill, Gloria M Petersen, Andrew D Rhim, Diane M Simeone, Sudhir Srivastava, Masao Tanaka, Aaron I Vinik, David Wong.   

Abstract

Pancreatic cancer (PC) is estimated to become the second leading cause of cancer death in the United States by 2020. Early detection is the key to improving survival in PC. Addressing this urgent need, the Kenner Family Research Fund conducted the inaugural Early Detection of Sporadic Pancreatic Cancer Summit Conference in 2014 in conjunction with the 45th Anniversary Meeting of the American Pancreatic Association and Japan Pancreas Society. This seminal convening of international representatives from science, practice, and clinical research was designed to facilitate challenging interdisciplinary conversations to generate innovative ideas leading to the creation of a defined collaborative strategic pathway for the future of the field. An in-depth summary of current efforts in the field, analysis of gaps in specific areas of expertise, and challenges that exist in early detection is presented within distinct areas of inquiry: Case for Early Detection: Definitions, Detection, Survival, and Challenges; Biomarkers for Early Detection; Imaging; and Collaborative Studies. In addition, an overview of efforts in familial PC is presented in an addendum to this article. It is clear from the summit deliberations that only strategically designed collaboration among investigators, institutions, and funders will lead to significant progress in early detection of sporadic PC.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25931254      PMCID: PMC4467589          DOI: 10.1097/MPA.0000000000000368

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  91 in total

1.  Noninvasive imaging of tumor progression, metastasis, and fibrosis using a nanobody targeting the extracellular matrix.

Authors:  Noor Jailkhani; Jessica R Ingram; Mohammad Rashidian; Steffen Rickelt; Chenxi Tian; Howard Mak; Zhigang Jiang; Hidde L Ploegh; Richard O Hynes
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-08       Impact factor: 11.205

2.  Microbial dysbiosis and polyamine metabolism as predictive markers for early detection of pancreatic cancer.

Authors:  Roberto Mendez; Kousik Kesh; Nivedita Arora; Leá Di Martino; Florencia McAllister; Nipun Merchant; Sulagna Banerjee; Santanu Banerjee
Journal:  Carcinogenesis       Date:  2020-07-10       Impact factor: 4.944

Review 3.  Non-invasive biomarkers in pancreatic cancer diagnosis: what we need versus what we have.

Authors:  Marta Herreros-Villanueva; Luis Bujanda
Journal:  Ann Transl Med       Date:  2016-04

4.  Plectin-1 as a Biomarker of Malignant Progression in Intraductal Papillary Mucinous Neoplasms: A Multicenter Study.

Authors:  Maria Moris; David W Dawson; Jennifer Jiang; Jason Lewis; Aziza Nassar; Kenneth K Takeuchi; Anna R Lay; Qihui Zhai; Timothy R Donahue; Kimberly A Kelly; Howard C Crawford; Michael Wallace
Journal:  Pancreas       Date:  2016-10       Impact factor: 3.327

5.  Detection of early pancreatic ductal adenocarcinoma with thrombospondin-2 and CA19-9 blood markers.

Authors:  Jungsun Kim; William R Bamlet; Ann L Oberg; Kari G Chaffee; Greg Donahue; Xing-Jun Cao; Suresh Chari; Benjamin A Garcia; Gloria M Petersen; Kenneth S Zaret
Journal:  Sci Transl Med       Date:  2017-07-12       Impact factor: 17.956

6.  Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer.

Authors:  Michela Capello; Leonidas E Bantis; Ghislaine Scelo; Yang Zhao; Peng Li; Dilsher S Dhillon; Nikul J Patel; Deepali L Kundnani; Hong Wang; James L Abbruzzese; Anirban Maitra; Margaret A Tempero; Randall Brand; Matthew A Firpo; Sean J Mulvihill; Matthew H Katz; Paul Brennan; Ziding Feng; Ayumu Taguchi; Samir M Hanash
Journal:  J Natl Cancer Inst       Date:  2017-04-01       Impact factor: 13.506

7.  A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns.

Authors:  Faiyaz Notta; Michelle Chan-Seng-Yue; Mathieu Lemire; Yilong Li; Gavin W Wilson; Ashton A Connor; Robert E Denroche; Sheng-Ben Liang; Andrew M K Brown; Jaeseung C Kim; Tao Wang; Jared T Simpson; Timothy Beck; Ayelet Borgida; Nicholas Buchner; Dianne Chadwick; Sara Hafezi-Bakhtiari; John E Dick; Lawrence Heisler; Michael A Hollingsworth; Emin Ibrahimov; Gun Ho Jang; Jeremy Johns; Lars G T Jorgensen; Calvin Law; Olga Ludkovski; Ilinca Lungu; Karen Ng; Danielle Pasternack; Gloria M Petersen; Liran I Shlush; Lee Timms; Ming-Sound Tsao; Julie M Wilson; Christina K Yung; George Zogopoulos; John M S Bartlett; Ludmil B Alexandrov; Francisco X Real; Sean P Cleary; Michael H Roehrl; John D McPherson; Lincoln D Stein; Thomas J Hudson; Peter J Campbell; Steven Gallinger
Journal:  Nature       Date:  2016-10-12       Impact factor: 49.962

8.  Prognostic significance of circulating tumor microemboli in patients with pancreatic ductal adenocarcinoma.

Authors:  Guangdong Wu; Rongrong Zhu; Yatong Li; Yupei Zhao; Menghua Dai
Journal:  Oncol Lett       Date:  2018-03-14       Impact factor: 2.967

9.  Fasting Blood Glucose Levels Provide Estimate of Duration and Progression of Pancreatic Cancer Before Diagnosis.

Authors:  Ayush Sharma; Thomas C Smyrk; Michael J Levy; Mark A Topazian; Suresh T Chari
Journal:  Gastroenterology       Date:  2018-04-30       Impact factor: 22.682

Review 10.  Leveraging Mechanisms Governing Pancreatic Tumorigenesis To Reduce Pancreatic Cancer Mortality.

Authors:  Timothy R Donahue; David W Dawson
Journal:  Trends Endocrinol Metab       Date:  2016-07-25       Impact factor: 12.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.